Tvardi Therapeutics (TVRD) Short Interest
Nasdaq • TVRD • US1407553072
As of Oct 27, 2026, ORTEX estimated 4.4% of free float sold short, 2.7 days to cover, cost to borrow 13.12%. Sign up for live short interest data.
Nasdaq • TVRD • US1407553072
As of Oct 27, 2026, ORTEX estimated 4.4% of free float sold short, 2.7 days to cover, cost to borrow 13.12%. Sign up for live short interest data.
This page tracks how heavily Tvardi Therapeutics (Nasdaq:TVRD) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Tvardi Therapeutics (Nasdaq: TVRD) has a market capitalization of $17.87M. Last close $1.34 (as of 2026-11-12); 52-week range $0.77 to $5.69. ORTEX data as of 2026-10-27: short interest was 4.35% of free float, 2.7 days to cover and the average cost to borrow was 13.12%. Sign up for live short interest data.